NCT06886256 Prehabilitation for Kidney Transplant Candidates
| NCT ID | NCT06886256 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Methodist Hospital Research Institute |
| Condition | Kidney Transplantation |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2025-03-26 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2025-03-26 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This interventional trial seeks to determine the feasibility of wearable sensors to provide data from patients while undergoing supervised exercise.
Eligibility Criteria
Inclusion Criteria: 1. Adult Frail patients who are being evaluated for kidney transplant at Houston Methodist Hospital 2. Male or Female, aged 55 or older 3. Provision of signed and dated informed consent by the participant 4. Willingness to comply with study procedures and the duration of the study Exclusion Criteria: 1. Inability or contraindication to exercise 2. Refusal to participate 3. Inability to consent or effectively communicate
Contact & Investigator
Atyia Dhala, MD
PRINCIPAL INVESTIGATOR
The Methodist Hospital Research Institute
Frequently Asked Questions
Who can join the NCT06886256 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, studying Kidney Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06886256 currently recruiting?
Yes, NCT06886256 is actively recruiting participants. Contact the research team at dwcleere@houstonmethodist.org for enrollment information.
Where is the NCT06886256 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06886256 clinical trial?
NCT06886256 is sponsored by The Methodist Hospital Research Institute. The principal investigator is Atyia Dhala, MD at The Methodist Hospital Research Institute. The trial plans to enroll 15 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.